Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ILOSONE SULFA

ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL

Standard Dose
EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ILOSONE SULFA is listed in Drugs@FDA under application 050599 (NDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML;EQ 600MG BASE/5ML Sponsor LILLY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ILOSONE SULFA is listed in Drugs@FDA under application 050599 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML;EQ 600MG BASE/5ML Sponsor LILLY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.